L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant ChemotherapyHiroshi Asano, Hidemichi Watari, Yutaka Hatanaka et al.|Annals of Surgical Oncology|2019Cited by 27
Tailored radical hysterectomy for locally advanced cervical cancerNoriaki Sakuragi, Hidemichi Watari, Masanori Kaneuchi et al.|International Journal of Gynecological Cancer|2020Cited by 7
Four versus six chemotherapy cycles in endometrial carcinoma with a high risk of recurrence: a retrospective studyMichinori Mayama, Hidemichi Watari, Hiroshi Asano et al.|Japanese Journal of Clinical Oncology|2020Cited by 5
Abstract 1612: Molecular analysis of clinically actionable gene alterations in clear cell carcinoma of the ovary using next-generation sequencing and immunohistochemical CNV analysisHiroshi Asano, Noriaki Sakuragi, Yutaka Hatanaka et al.|Cancer Research|2018Cited by 0
P77 L1CAM is an independent predictor of poor survival of endometrial cancer undergoing full lymphadenectomy and adjuvant chemotherapyAkira Oku, Hidemichi Watari, Hiroshi Asano et al.|International Journal of Gynecological Cancer|2019Cited by 0